Cortical Cataract Clinical Trial
Official title:
A Prospective Randomized Controlled Clinical Trial Comparing the Intra-operative Effects, Safety, Efficacy and Performance of Two Commercially Available Laser Systems in Patients Undergoing Femtosecond Laser-Assisted Cataract Surgery.
This study compares two FDA approved Cataract Lasers.
The purpose of this study is to systematically evaluate the performance of two commercially
available and FDA cleared femtosecond laser systems in patients undergoing femtosecond
laser-assisted cataract surgery. Objective data on the repeatability and accuracy of the
studied parameters will be gathered and reported as endpoints of the study.
The two systems studied are the Catalys™ Precision Laser System (OptiMedica, CA, USA) and
the LenSx® Laser System (Alcon Laboratories, Inc., Fort Worth, TX).
Published data have suggested that the femtosecond laser is a useful tool for cataract
surgery.
This study is to determine whether differences or similarities exist in specific treatment
parameters achieved with two FDA cleared and commercially available femtosecond laser
cataract surgery platforms
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04975971 -
A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery
|
||
Completed |
NCT03819842 -
Evaluating the Need for the Pseudophakic Intraoperative Abberrometry in Toric IOL Implantation
|
N/A |